ASN Publications

Showcasing the latest in kidney care, research, and innovation. Follow for updates from ASN publications, including JASN, CJASN, Kidney360, and Kidney News.

[ASN Publications @asnpublications]

August issue of JASN is now available online! Topics covered include:
- Calorie Restriction in a Mouse Model of UMOD-Related Kidney Disease
- Community/EMR Approach to APOL1 Screening for RCT in APOL1-Mediated Kidney Disease
https://t.co/R1zoQB9PQ3
#ASNJASN Cover by Ha et al.

[ASN Publications @asnpublications]

Pulmonary hypertension is a common and underrecognized complication of CKD, driving higher cardiovascular risk and mortality. More research is needed to define mechanisms, track right ventricular changes, and develop effective treatments, according to #ASNCJASN. https://t.co/QAAmdgcHIJ

[ASN Publications @asnpublications]

Clinical trials rely on the Cockcroft-Gault equation for kidney function assessment. In this #Perspective, the authors argue that adopting contemporary, race-free eGFR methods could improve patient selection, dosing, and relevance of findings to clinical practice. https://t.co/QR4ONdNxTm #ASNJASN

[ASN Publications @asnpublications]

New Podcast: In this #ASNCJASN podcast, "Trends in Vascular Access Placement,” Drs. Allon and Lee summarize the main findings from their study. Tune in here: https://t.co/AVMbwI0yXT

[ASN Publications @asnpublications]

Cancer therapy-associated renal TMA is often diagnosed late. Research in #ASNKidney360 shows that gemcitabine was the most common cause, with doxorubicin and erlotinib emerging as underrecognized culprits. Early recognition may improve kidney outcomes. #OncoNephrology https://t.co/DglaBm0Qm0

[ASN Publications @asnpublications]

Medicare Advantage may lower out-of-pocket costs for some patients with kidney failure, but many still face substantial medical bills. Dialysis providers report concerns that growing financial pressures could ultimately affect patients’ access to high-quality care. https://t.co/eTj8kJTUoT #ASNCJASN

[ASN Publications @asnpublications]

"The first 6 months of this year may have represented a new highwater mark for ASN's effectiveness on the Hill." @ASNKidney President @samirparikhmd reflects on the years of ASN's advocacy to improve the lives of people living with kidney diseases: https://t.co/BYvbGT3yE5

#ASNKidneyNews

[ASN Publications @asnpublications]

APRT deficiency drives DHA crystal deposition in the kidney, with greater crystal burden linked to more inflammation and fibrosis. These findings reported in #ASNKidney360 support a crystal-mediated pathway of progressive kidney injury and CKD. #CKD https://t.co/Ylpwll7REu

[ASN Publications @asnpublications]

What prevents kidney transplant recipients from pursuing re-transplantation after graft loss? Interviews across 11 Canadian programs identified key barriers. Living donor re-transplantation faced additional donor, psychological, and structural challenges. https://t.co/gu7KOCFcRZ #ASNCJASN

[ASN Publications @asnpublications]

What makes medical learning stick? In this #ASNKidneyNews special section article, authors explore the evidence behind active learning, mentorship, and collaborative medical educational models that help knowledge endure. https://t.co/aRNUtcrcgh

[ASN Publications @asnpublications]

In ADPKD, eGFR from race-free CKD-EPI equations correlated similarly with htTKV, with stronger associations in higher Mayo Imaging Classes. Among patients with measured GFR, CKD-EPI creatinine-cystatin C was the most accurate, supporting its use when mGFR is unavailable. https://t.co/SOxNyGFTKc #ASNKidney360

[ASN Publications @asnpublications]

#ASNCJASN launches the Bridging Cardiovascular and Kidney Health Series, spotlighting the powerful heart-kidney connection, transformative CKD therapies, and opportunities to improve prevention, implementation, and patient outcomes. https://t.co/Z4xfZvFFBR

[ASN Publications @asnpublications]

For patients with cancer undergoing dialysis, how should clinicians weigh the benefits of erythropoiesis-stimulating agents against potential cancer risks? https://t.co/R5W3p6hg9u

#ASNKidneyNews

[ASN Publications @asnpublications]

ARHF remains underrecognized despite vascular access accounting for 23% of high-output HF cases, with 58% 5-year mortality. This review covers pathophysiology, diagnostics, risk assessment, and treatment strategies to improve patient outcomes. https://t.co/AGEkPWxuiS #ASNKidney360

[ASN Publications @asnpublications]

In this #ASNKidneyNews Creative Cortex, artist Anil Saxena powerfully visualizes the convergence of pregnancy and kidney disease. Explore it here: https://t.co/iE8jY0kk3x

Submit your own creative work to be featured in an upcoming issue: https://t.co/1EHtHcaoHv

[ASN Publications @asnpublications]

Creatinine is rising. But is the kidney really to blame? Detective Nephron and Mackenzie Ula Densa tackle a puzzling case that challenges assumptions and puts your clinical reasoning to the test: https://t.co/X0x1GCn3Tf

#ASNKidneyNews @kdjhaveri

[ASN Publications @asnpublications]

In septic shock, uremic toxins rose with AKI severity, with indoxyl sulfate most strongly linked to creatinine. KRT lowered many toxins, but UT trajectories did not independently predict 28-day mortality or recovery outcomes, according to a study in #ASNKidney360. https://t.co/4gAdVMmrRI

[ASN Publications @asnpublications]

RAAS inhibitors remain the cornerstone of care, while SGLT2 inhibitors and GLP-1 RAs show promise. Evidence for MRAs and ARNIs is still limited, highlighting the need for dedicated RCTs, according to review article in #ASNCJASN. https://t.co/6Rjb4VTHyt #CKM

[ASN Publications @asnpublications]

When should CRRT liberation be tested in children and young adults with AKI? An early liberation trial in patients with ongoing urine output was linked to better outcomes, including more ICU- and hospital-free days, supporting early readiness assessment. https://t.co/QPnQhXfLtv #ASNCJASN

[ASN Publications @asnpublications]

Is it time for clinicians to rethink “fistula first” for every older dialysis patient? The best access may be the one that aligns with the patient’s health, priorities, and quality of life, according to new research published in #ASNJASN. https://t.co/KFYQaSZtUj

[ASN Publications @asnpublications]

In the latest #ASNKidneyNews Business Round-Up, explore the key developments from the first half of 2026 that are driving kidney care and innovation: https://t.co/J0eF8CVzTG